Dupilumab
Catalogue number:
HY-P9926-1mg
Supplier:
Size:
1 mg
Product is available in:
Applications:
COVID-19-immunoregulation
Target:
Interleukin Related
Alternative Names:
REGN-668; SAR-231893
- Data sheet: View or download
- MSDS: View or download
- Protocol: View or download
Product Description:
Dupilumab (REGN-668) is a fully human mAb to IL-4 receptor α (IL-4Rα) that inhibits both IL-4 and IL-13 signaling, markedly improved moderate-to-severe atopic dermatitis[1].